Elsevier

Neuropharmacology

Volume 31, Issue 10, October 1992, Pages 991-995
Neuropharmacology

Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis

https://doi.org/10.1016/0028-3908(92)90099-BGet rights and content

Abstract

The anxiolytic agent buspirone was administered subcutaneously twice a day for 10 days to Sprague-Dawley rats, at a dose of 3 mg kg−1. Controls were given saline. On the eleventh day, the rats were given an injection of NSD-1015, an aromatic L-amino acid decarboxylase inhibitor, 30 min before decapitation. To another group of rats, only one injection of buspirone was given, followed 30 min later by NSD-1015. After a further 30 min the animals were decapitated. The brains were rapidly removed and the raphe nuclei, striatum, hippocampus and cerebellum were dissected out on to dry ice. With the use of HPLC, the four regions of the brain were assayed for 5-hydroxytryptophan and 3,4-dihydroxyphenylalanine, reflecting the synthesis of 5-HT and dopamine, respectively. In those rats which had received an acute dose of buspirone, the synthesis of 5-HT was substantially reduced in all four regions of the brain. However, in those rats which had received buspirone for 10 days, no such alterations in the synthesis of 5-HT were observed. The synthesis of dopamine was unchanged in any of the regions of the brain, after the acute dose of buspirone. After 10 days of treatment with buspirone, however, the synthesis of dopamine in the striatum was significantly reduced. These findings suggest that repeated treatment with buspirone reduces the synthesis of dopamine in the striatum but that the synthesis of 5-HT is unaffected.

References (28)

  • S. Garattini et al.

    Notes on buspirone's mechanisms of action

    J. clin. Psychiat.

    (1982)
  • H.L. Goldberg et al.

    The comparative efficacy of buspirone and diazepam in the treatment of anxiety

    Am. J. Psychiat.

    (1979)
  • J.A. Gray

    The Neuropsychology of Anxiety

    (1982)
  • S. Hjorth et al.

    8-Hydroxy-2-(di-n-propylamino-tetralin, 8-OH-DPAT, a potent and selective simplified ergot cogener with central 5-HT receptor stimulating activity

    J. Neural Transm.

    (1982)
  • Cited by (28)

    • Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats

      2011, Behavioural Brain Research
      Citation Excerpt :

      ESCIT (10 mg/kg) and BUSP (3 mg/kg) were injected (s.c. in a volume of 1 ml/kg) daily between 8:00 and 10:00 for 20 days. These doses of ESCIT [38,51] and BUSP [26,33,63] were chosen based on previous experimental studies. A week before the actual experimental testing, all animals received 1 ml saline injection 3 times on alternating days in order to habituate to the injection procedure.

    • Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray

      2010, Experimental Neurology
      Citation Excerpt :

      ESCIT (10 mg/kg) and BUSP (3 mg/kg) were injected (s.c. in a volume of 1 ml/kg) 60 min and 120 min before behavioural testing, respectively. The doses of ESCIT (Lugenbiel et al., 2009; Sanchez et al., 2003) and BUSP (Kakui et al., 2009; Lim et al., 2008b; Tunnicliff et al., 1992) were chosen based on its effective pharmacological profile of previous experimental studies. A week before the actual experimental testing, all animals received 1 ml saline injection 3 times on alternating days in order to habituate the animals to the injection procedure.

    • Effects of buspirone on an animal model of tardive dyskinesia

      1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    View full text